Gesine Meyer‐Rath

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

Jeffrey W. Eaton, Nicolas A. Menzies, John Stover et al. · The Lancet Global Health · 2013 · 244 citations · Full text

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

Gesine Meyer‐Rath, Kathryn Schnippel, Lawrence Long et al. · PLoS ONE · 2012 · 159 citations · Full text

Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study

Katharina Kranzer, Stephen D Lawn, Gesine Meyer‐Rath et al. · PLoS Medicine · 2012 · 74 citations · Full text

Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness

Leigh F. Johnson, Craig van Rensburg, Caroline Govathson et al. · Scientific Reports · 2019 · 72 citations · Full text

HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions

Gesine Meyer‐Rath, Mead Over · PLoS Medicine · 2012 · 64 citations · Full text

Preventive Medicine, Art Provision, Future Directions +21